301 related articles for article (PubMed ID: 27363923)
1. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases.
Sadek B; Saad A; Sadeq A; Jalal F; Stark H
Behav Brain Res; 2016 Oct; 312():415-30. PubMed ID: 27363923
[TBL] [Abstract][Full Text] [Related]
2. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions.
Rapanelli M; Pittenger C
Neuropharmacology; 2016 Jul; 106():85-90. PubMed ID: 26282120
[TBL] [Abstract][Full Text] [Related]
3. The neglected role of histamine in Alzheimer's disease.
Naddafi F; Mirshafiey A
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):327-36. PubMed ID: 23677734
[TBL] [Abstract][Full Text] [Related]
4. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Esbenshade TA; Fox GB; Cowart MD
Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
[TBL] [Abstract][Full Text] [Related]
5. Histamine-selective H3 receptor ligands and cognitive functions: an overview.
Vohora D
IDrugs; 2004 Jul; 7(7):667-73. PubMed ID: 15243869
[TBL] [Abstract][Full Text] [Related]
6. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
7. Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
Ellenbroek BA; Ghiabi B
Curr Pharm Des; 2015; 21(26):3760-70. PubMed ID: 26044979
[TBL] [Abstract][Full Text] [Related]
8. Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Eissa N; Sadeq A; Sasse A; Sadek B
Front Pharmacol; 2020; 11():886. PubMed ID: 32612529
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.
Alhusaini M; Eissa N; Saad AK; Beiram R; Sadek B
Front Pharmacol; 2022; 13():861094. PubMed ID: 35721194
[TBL] [Abstract][Full Text] [Related]
10. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
11. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE
Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772
[TBL] [Abstract][Full Text] [Related]
12. [The roles of histamine H3 receptors in the behavioral disorders and neuropsychopharmacological aspects of its ligands in the brain].
Onodera K; Miyazaki S
Nihon Yakurigaku Zasshi; 1999 Aug; 114(2):89-106. PubMed ID: 10511950
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
[TBL] [Abstract][Full Text] [Related]
14. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
15. Role of the Histamine H
Schlicker E; Kathmann M
Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.
Di Ciano P; Hendershot CS; Le Foll B
Curr Top Behav Neurosci; 2022; 59():169-191. PubMed ID: 35704272
[TBL] [Abstract][Full Text] [Related]
17. Histamine H3 receptors and sleep-wake regulation.
Lin JS; Sergeeva OA; Haas HL
J Pharmacol Exp Ther; 2011 Jan; 336(1):17-23. PubMed ID: 20864502
[TBL] [Abstract][Full Text] [Related]
18. Region-specific regulation of central histaminergic H3 receptor expression in a mouse model of cow's milk allergy.
Germundson DL; Vendsel LP; Nagamoto-Combs K
Brain Res; 2020 Dec; 1749():147148. PubMed ID: 33035498
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of histamine H3 receptor antagonists in dementias.
Chazot PL
Drug News Perspect; 2010 Mar; 23(2):99-103. PubMed ID: 20369074
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of histamine H3 receptor agonists and antagonists.
Leurs R; Blandina P; Tedford C; Timmerman H
Trends Pharmacol Sci; 1998 May; 19(5):177-83. PubMed ID: 9652190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
